Analysed OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) News Sources
Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
23-04-2026
yahoo.com
Outlook Therapeutics Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
15-05-2026
yahoo.com
Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
26-05-2026
yahoo.com
OTLK Stock Surges Over 50% Pre-Market, Breaches Key Technical Milestone – What’s Behind This Massive Rally?
26-05-2026
stocktwits.com
OTLK Stock Rocket Nearly 140%: Lytenava Dispute Resolution With FDA Pushes Stock On Track For Best Week On Record
28-05-2026
stocktwits.com
Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
28-05-2026
yahoo.com
Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
01-06-2026
yahoo.com
What is the current price of OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ)?
The current price of OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) is $0.8098.
OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) absolute price change since previous trading day?
The absolute price change of OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) since the previous trading day is $-0.0038.
OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) percentage price change since previous trading day?
The percentage price change of OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) since the previous trading day is -0.4671%.
What is the most recent average sentiment score for OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ)?
The most recent average sentiment score for OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) is 49 out of 100.
What is the most recent average sentiment for OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ)?
The most recent sentiment for OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ) is .
SEC-8K** Filing Available For OUTLOOK THERAPEUTICS INC (OTLK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.